Reuters
@Reuters·4.2M subscribers·86.9K videos
Wegovy sales double, but Novo Nordisk expects slower growth in 2025 | REUTERS
Posted
February 5, 2025
Views
1,065
Likes
15
Engagement
1.41%
February 5, 2025
1,065
15
1.41%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
1:16Now PlayingObesity drug maker Novo Nordisk forecast slower growth this year after Wegovy sales more than doubled in Q4, easing investor concerns over competition from Eli Lilly.
#News #wegovy #novonordisk #obesitydrug #health #earnings #Reuters #Newsfeed
Read the story here
👉 Subscribe
Keep up with the latest news from around the world
Follow Reuters on Facebook
Follow Reuters on Twitter
Follow Reuters on Instagram
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
